These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9248603)

  • 1. Handling of gene-transfer products by the National Institutes of Health Clinical Center pharmacy department.
    DeCederfelt HJ; Grimes GJ; Green L; DeCederfelt RO; Daniels CE
    Am J Health Syst Pharm; 1997 Jul; 54(14):1604-10. PubMed ID: 9248603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are UK hospital pharmacy departments ready for the rise of gene therapy medicinal products?
    Stoner N
    Expert Opin Biol Ther; 2018 Aug; 18(8):837-840. PubMed ID: 29962243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral-mediated gene therapy and genetically modified therapeutics: A primer on biosafety handling for the health-system pharmacist.
    Blind JE; McLeod EN; Campbell KJ
    Am J Health Syst Pharm; 2019 May; 76(11):795-802. PubMed ID: 31361814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    ; Gangadharan D; Smith J; Weyant R
    MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived versus real risks of handling gene transfer agents in the pharmacy environment.
    Ellison SL; Hunt DL
    Am J Health Syst Pharm; 2010 May; 67(10):838-48. PubMed ID: 20479107
    [No Abstract]   [Full Text] [Related]  

  • 7. Technical considerations in the preparation and dispensing of chemotherapy.
    Peters BG
    Top Hosp Pharm Manage; 1995 Jan; 14(4):78-88. PubMed ID: 10140430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals and home infusion facilities--1995.
    Santell JP; Kamalich RF
    Am J Health Syst Pharm; 1996 Nov; 53(21):2591-605. PubMed ID: 8913388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel.
    Alexander M; King J; Lingaratnam S; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M
    J Oncol Pharm Pract; 2016 Apr; 22(2):219-27. PubMed ID: 25398311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons to be Learned from Recent Biosafety Incidents in the United States.
    Weiss S; Yitzhaki S; Shapira SC
    Isr Med Assoc J; 2015 May; 17(5):269-73. PubMed ID: 26137650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy program for improved handling of antineoplastic agents.
    Scott SA; Schrott DB; Loesch GA
    Am J Hosp Pharm; 1983 Jul; 40(7):1179-82. PubMed ID: 6881156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic biology and occupational risk.
    Howard J; Murashov V; Schulte P
    J Occup Environ Hyg; 2017 Mar; 14(3):224-236. PubMed ID: 27754800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manufacturers' recommendations for handling spilled antineoplastic agents.
    Johnson EG; Janosik JE
    Am J Hosp Pharm; 1989 Feb; 46(2):318-9. PubMed ID: 2712057
    [No Abstract]   [Full Text] [Related]  

  • 15. The OSHA lowdown on occupational exposure to bloodborne pathogens.
    Gile TJ
    MLO Med Lab Obs; 2001 Jun; 33(6):14-20; quiz 22-3. PubMed ID: 11424285
    [No Abstract]   [Full Text] [Related]  

  • 16. Safe handling of antineoplastic drugs.
    Harrison BR
    Top Hosp Pharm Manage; 1994 Jul; 14(2):1-10. PubMed ID: 10136200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A report on the National Commission on Cytotoxic Exposure.
    Gallelli JF
    J Pharm Technol; 1992; 8(2):55-64. PubMed ID: 10118896
    [No Abstract]   [Full Text] [Related]  

  • 18. Handling antineoplastic-drug admixtures at cancer centers: practices and pharmacist attitudes.
    Gregoire RE; Segal R; Hale KM
    Am J Hosp Pharm; 1987 May; 44(5):1090-5. PubMed ID: 3605119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists.
    Unda-Urzáiz M; Alonso-Herreros JM; Fernández-Gómez JM; Gaspar-Carreño M; Cozar-Olmos JM; Cercós Lleti AC
    Farm Hosp; 2018 Sep; 42(5):212-215. PubMed ID: 30173640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance: ensuring pharmacy personnel follow procedures for handling cytotoxic drugs.
    Scott BE; White SJ; Matthews T
    Hosp Pharm; 1987 Jan; 22(1):45-9. PubMed ID: 10280293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.